A rare cause of dystonia in an adolescent with insulin resistance (IR): a case report

Lordudass, Alexis and Yin, Jay Lim and Noordin, Mazidah and Bashkar, Shalini and Ahmad Fauzi, Nor Amelia and Mohd Nor, Noor Shafina (2026) A rare cause of dystonia in an adolescent with insulin resistance (IR): a case report. Journal of Clinical and Health Sciences (JCHS), 11 (SUPP2). pp. 53-54. ISSN 0127-984X
Abstract

Metformin (MTF) is first line pharmacological therapy for insulin resistance (IR) used alongside healthy lifestyle modifications. Additionally, Risperidone is approved for irritability and aggression management in autism. Both medications are metabolised via the kidneys.

Item Details
Edit Item
Edit Item
Downloads & Files
[thumbnail of 147715.pdf]
Text
147715.pdf
Download (267kB)
Indexing & Metrics